首页> Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie> Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization.

Obstetrical Impact of Anti-MUT (Anti-MNS35) Alloimmunization.

导出 OA

翻译打印收藏纠错

第一作者： Mathilde,Gavillet

第一单位： Interregional Blood Transfusion SRC Bern Ltd., Bern, Switzerland.;Service and Central Laboratory of Hematology, Departments of Oncology and Laboratories and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

作者： Mathilde,Gavillet ^[1] ; Tobias,Gleich-Nagel ^[2] ; Helene,Legardeur ^[3] ; David,Baud ^[3] ; Noemy,Friedrich ^[4] ; Christine,Henny ^[2] ; Giorgia,Canellini ^[2] ; Emeline,Maisonneuve ^[3] ; Sofia,Lejon Crottet ^[2]

作者单位： Interregional Blood Transfusion SRC Bern Ltd., Bern, Switzerland.;Service and Central Laboratory of Hematology, Departments of Oncology and Laboratories and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland. ^[1] Interregional Blood Transfusion SRC Bern Ltd., Bern, Switzerland. ^[2] Materno-fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. ^[3] Service and Central Laboratory of Hematology, Departments of Oncology and Laboratories and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland. ^[4]

关键词 Alloimmunization Anti-MUT antibody GYPA*Hut (MNS35)Hemolytic disease of the fetus and newborn Low-prevalence antigen

DOI 10.1159/000550751

PMID 41924285

发布时间 2026-04-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交